tiprankstipranks
TransMedics Group Inc (TMDX)
NASDAQ:TMDX
US Market

TransMedics Group (TMDX) Financial Statements

Compare
1,351 Followers

TransMedics Group Financial Overview

TransMedics Group's market cap is currently $2.39B. The company's EPS TTM is $1.01; its P/E ratio is 66.99; TransMedics Group is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $0.26. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 441.54M$ 241.62M$ 93.46M$ 30.26M$ 25.64M
Gross Profit$ 262.08M$ 154.09M$ 65.27M$ 21.16M$ 16.64M
Operating Income$ 37.50M$ -28.73M$ -31.44M$ -39.43M$ -26.38M
EBITDA$ 69.95M$ -7.60M$ -28.96M$ -38.49M$ -23.15M
Net Income$ 35.46M$ -25.03M$ -36.23M$ -44.22M$ -28.75M
Balance Sheet
Cash & Short-Term Investments$ 336.65M$ 394.81M$ 201.18M$ 92.45M$ 125.64M
Total Assets$ 804.08M$ 706.05M$ 277.15M$ 134.89M$ 152.03M
Total Debt$ 458.92M$ 515.95M$ 67.56M$ 8.60M$ 34.66M
Net Debt$ 122.27M$ 121.13M$ -133.63M$ -16.98M$ 10.08M
Total Liabilities$ 575.47M$ 568.85M$ 89.77M$ 67.04M$ 48.13M
Stockholders' Equity$ 228.60M$ 137.20M$ 187.38M$ 67.85M$ 103.89M
Cash Flow
Free Cash Flow$ 48.80M$ -192.09M$ -57.72M$ -32.38M$ -30.72M
Operating Cash Flow$ 48.80M$ -13.03M$ -45.82M$ -28.86M$ -30.27M
Investing Cash Flow$ -129.30M$ -193.95M$ 54.51M$ 29.27M$ -41.60M
Financing Cash Flow$ 22.87M$ 400.42M$ 167.93M$ 1.39M$ 75.55M
Currency in USD

TransMedics Group Earnings and Revenue History

TransMedics Group Debt to Assets

TransMedics Group Cash Flow

TransMedics Group Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis